These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28505188)

  • 1. Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.
    Pittman JE; Noah H; Calloway HE; Davis SD; Leigh MW; Drumm M; Sagel SD; Accurso FJ; Knowles MR; Sontag MK
    PLoS One; 2017; 12(5):e0177215. PubMed ID: 28505188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The determinants of survival among adults with cystic fibrosis-a cohort study.
    Durda-Masny M; Goździk-Spychalska J; John A; Czaiński W; Stróżewska W; Pawłowska N; Wlizło J; Batura-Gabryel H; Szwed A
    J Physiol Anthropol; 2021 Nov; 40(1):19. PubMed ID: 34749804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis.
    Dorfman R; Taylor C; Lin F; Sun L; Sandford A; Paré P; Berthiaume Y; Corey M; Durie P; Zielenski J;
    Pediatr Pulmonol; 2011 Apr; 46(4):385-92. PubMed ID: 20967843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
    Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
    Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for the progression of cystic fibrosis lung disease throughout childhood.
    Sanders DB; Li Z; Laxova A; Rock MJ; Levy H; Collins J; Ferec C; Farrell PM
    Ann Am Thorac Soc; 2014 Jan; 11(1):63-72. PubMed ID: 24261460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Viel M; Hubert D; Burgel PR; Génin E; Honoré I; Martinez B; Gaitch N; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T
    Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Pseudomonas aeruginosa infection stage with lung function trajectory in children with cystic fibrosis.
    Rosenfeld M; Faino AV; Qu P; Onchiri FM; Blue EE; Collaco JM; Gordon WW; Szczesniak R; Zhou YH; Bamshad MJ; Gibson RL
    J Cyst Fibros; 2023 Sep; 22(5):857-863. PubMed ID: 37217389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in lung clearance index with microbiological status in children with cystic fibrosis.
    Walicka-Serzysko K; Postek M; Milczewska J; Sands D
    Pediatr Pulmonol; 2019 Jun; 54(6):729-736. PubMed ID: 30838817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis.
    Dassios TG; Katelari A; Doudounakis S; Dimitriou G
    Respir Care; 2014 Mar; 59(3):363-70. PubMed ID: 23983273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis.
    Keating CL; Liu X; Dimango EA
    Chest; 2010 May; 137(5):1157-63. PubMed ID: 19965956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental allergies and respiratory morbidities in cystic fibrosis.
    Collaco JM; Morrow CB; Green DM; Cutting GR; Mogayzel PJ
    Pediatr Pulmonol; 2013 Sep; 48(9):857-64. PubMed ID: 23143815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Association With
    Nourkami-Tutdibi N; Freitag K; Zemlin M; Tutdibi E
    Front Immunol; 2021; 12():587313. PubMed ID: 33679736
    [No Abstract]   [Full Text] [Related]  

  • 13. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.
    West SE; Zeng L; Lee BL; Kosorok MR; Laxova A; Rock MJ; Splaingard MJ; Farrell PM
    JAMA; 2002 Jun; 287(22):2958-67. PubMed ID: 12052125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal screening of cystic fibrosis: diagnostic problems with CFTR mild mutations.
    Roussey M; Le Bihannic A; Scotet V; Audrezet MP; Blayau M; Dagorne M; David V; Deneuville E; Giniès JL; Laurans M; Moisan-Petit V; Rault G; Vigneron P; Férec C
    J Inherit Metab Dis; 2007 Aug; 30(4):613. PubMed ID: 17632692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
    Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
    Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients.
    Levy H; Kalish LA; Cannon CL; García KC; Gerard C; Goldmann D; Pier GB; Weiss ST; Colin AA
    Pediatr Pulmonol; 2008 May; 43(5):463-71. PubMed ID: 18361452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Italian Cystic Fibrosis Registry (ICFR). Report 2021-2022].
    Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2024; 48(2 Suppl 2):1-41. PubMed ID: 38742380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry.
    Vongthilath R; Richaud Thiriez B; Dehillotte C; Lemonnier L; Guillien A; Degano B; Dalphin ML; Dalphin JC; Plésiat P
    PLoS One; 2019; 14(1):e0210201. PubMed ID: 30620748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK CF registry-based study.
    Schlüter DK; Southern KW; Dryden C; Diggle P; Taylor-Robinson D
    Thorax; 2020 Feb; 75(2):123-131. PubMed ID: 31771956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.